Nonalcoholic fatty liver disease (NAFLD), recently renamed metabolic-associated fatty liver
disease (MAFLD), is one of the most common causes of liver diseases worldwide. NAFLD is …

Simple Summary Hepatocellular carcinoma (HCC) is an aggressive human cancer and is
caused as consequences of chronic liver diseases. Although HCC is more common in …

The global prevalence of nonalcoholic fatty liver disease (NAFLD) or metabolic associated
fatty liver disease (MAFLD), as it is now known, has gradually increased. NAFLD is a …

Background Insulin resistance (IR) during gestational diabetes mellitus (GDM) has been
linked to dysregulated insulin-PI3K/Akt pathway. A defective insulin-PI3K/Akt pathway and …

Nonalcoholic fatty liver disease (NAFLD) is a global health threat. Here, we presented the
significant role of a novel signaling axis comprising long non-coding RNA maternally …

Nonalcoholic fatty liver disease (NAFLD) is considered a hepatic manifestation of metabolic
syndrome, characterized from pathological changes in lipid and carbohydrate metabolism …

The rising prevalence of metabolic diseases related to insulin resistance (IR) have stressed
the urgent need of accurate and applicable tools for early diagnosis and treatment. In the …

Purpose Non-alcoholic fatty liver disease (NAFLD) is a disease associated with genetic-
environmental-metabolic stress, which severely damages the liver function of patients. This …

Noncoding RNAs (ncRNAs), including circular RNAs (circRNAs) and N6-methyladenosine
(m6A), have been shown to play a critical role in the development of various diseases …

Nonalcoholic fatty liver disease (NAFLD) refers to the pathologic buildup of extra fat in the
form of triglycerides in liver cells without excessive alcohol intake. NAFLD became the most …